Actuate Therapeutics, Inc.
ACTU- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001652935
No open-market purchases or sales by Actuate Therapeutics, Inc. insiders were filed in the last 90 days; 62 institutions reported holding it in 13F filings for Q2 2026, worth $20.6M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Actuate Therapeutics, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 25 | 38 | +13 |
| Shares | 10.4M | 11.2M | +815.6K (+7.8%) |
| Value | $70.4M | $68.5M | −$1.90M (−2.7%) |
New holders (21)
Institutions that held Actuate Therapeutics, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Barclays PLC | 37,334 | $228.1K | 0.00% |
| State Street Corp | 31,414 | $191.9K | 0.00% |
| Gleason Group, Inc. | 19,028 | $116.3K | 0.01% |
| LPL Financial LLC | 18,705 | $114.3K | 0.00% |
| New York State Common Retirement Fund | 17,200 | $105.1K | 0.00% |
| Charles Schwab Investment Management Inc | 14,765 | $90.2K | 0.00% |
| Wells Fargo & Company | 12,796 | $78.2K | 0.00% |
| Deutsche Bank AG | 10,439 | $63.8K | 0.00% |
| Rhumbline Advisers | 9,082 | $55.5K | 0.00% |
| Global Retirement Partners, LLC | 6,250 | $38.2K | 0.00% |
| Tang Capital Management LLC | 5,243 | $32.0K | 0.00% |
| Mirae Asset Global ETFs Holdings Ltd. | 3,189 | $19.5K | 0.00% |
| JPMorgan Chase & Co | 2,780 | $17.0K | 0.00% |
| Advisor Group Holdings, Inc. | 1,000 | $6.11K | 0.00% |
| BNP Paribas Arbitrage, SA | 905 | $5.53K | 0.00% |
| Legal & General Group Plc | 708 | $4.33K | 0.00% |
| Ameritas Investment Partners, Inc. | 601 | $3.67K | 0.00% |
| California State Teachers Retirement System | 367 | $2.24K | 0.00% |
| FMR LLC | 311 | $1.90K | 0.00% |
| Amalgamated Bank | 201 | $1.00K | 0.00% |
| Sterling Capital Management LLC | 14 | $86 | 0.00% |
Sold out (8)
Institutions that held Actuate Therapeutics, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Susquehanna International Group, LLP | 47,634 | $322.5K |
| Sigma Planning Corp | 23,675 | $160.3K |
| Goldman Sachs Group Inc | 22,358 | $151.4K |
| Mercer Global Advisors Inc | 16,344 | $110.6K |
| Marshall Wace, LLP | 16,114 | $109.1K |
| Citadel Advisors LLC | 14,185 | $96.0K |
| Millennium Management LLC | 12,185 | $82.5K |
| KG&L Capital Management,LLC | 12,000 | $81.2K |